More prominent muscle involvement in patients with dermatomyositis with anti-Mi2 autoantibodies

OBJECTIVE: To define the clinical phenotype of dermatomyositis (DM) with anti-Mi2 autoantibodies. METHODS: In this longitudinal cohort study, the prevalence and severity of clinical features at disease onset and during follow-up in patients with anti-Mi2–positive DM were compared to patients with an...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neurology
Main Authors: Pinal-Fernandez, Iago, Mecoli, Christopher A., Casal-Dominguez, Maria, Pak, Katherine, Hosono, Yuji, Huapaya, Julio, Huang, Wilson, Albayda, Jemima, Tiniakou, Eleni, Paik, Julie J., Johnson, Cheilonda, Danoff, Sonye K., Corse, Andrea M., Christopher-Stine, Lisa, Mammen, Andrew L.
Formato: Artigo
Idioma:Inglês
Publicado: Lippincott Williams & Wilkins 2019
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6946486/
https://ncbi.nlm.nih.gov/pubmed/31594859
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000008443
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares